Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Chemistry & Biology
|
September 17, 2013
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells
Jared J Barrott, Philip F Hughes, Takuya Osada, et al.
International Journal of Cancer
|
October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo
Michael A Morse, Junping Wei, Zachary Hartman, et al.
ACS Chemical Biology
|
January 20, 2017
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo
Lauren B Crowe, Philip F Hughes, David A Alcorta, et al.
Molecular Cancer Therapeutics
|
June 16, 2011
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors
Wenle Xia, Zuguo Liu, Rongrong Zong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity
Zachary C Hartman, Junping Wei, Takuya Osada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2019
Vaccine-Induced Memory CD8<sup>+</sup> T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Erika J Crosby, William Gwin, Kimberly Blackwell, et al.
Plos One
|
October 11, 2012
Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system
Nicholas C D'Amato, Julie H Ostrander, Michelle L Bowie, et al.
Cancer Immunology, Immunotherapy : CII
|
April 30, 2013
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
Michael A Morse, Arvind Chaudhry, Elizabeth S Gabitzsch, et al.
Plos One
|
September 2, 2016
X-Ray Psoralen Activated Cancer Therapy (X-PACT)
Mark Oldham, Paul Yoon, Zak Fathi, et al.
Molecular Cancer Therapeutics
|
October 22, 2021
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study
Takuya Osada, Erika J Crosby, Kensuke Kaneko, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Chemistry & Biology
|
September 17, 2013
Optical and radioiodinated tethered Hsp90 inhibitors reveal selective internalization of ectopic Hsp90 in malignant breast tumor cells
Jared J Barrott, Philip F Hughes, Takuya Osada, et al.
International Journal of Cancer
|
October 27, 2009
Synergism from combined immunologic and pharmacologic inhibition of HER2 in vivo
Michael A Morse, Junping Wei, Zachary Hartman, et al.
ACS Chemical Biology
|
January 20, 2017
A Fluorescent Hsp90 Probe Demonstrates the Unique Association between Extracellular Hsp90 and Malignancy in Vivo
Lauren B Crowe, Philip F Hughes, David A Alcorta, et al.
Molecular Cancer Therapeutics
|
June 16, 2011
Truncated ErbB2 expressed in tumor cell nuclei contributes to acquired therapeutic resistance to ErbB2 kinase inhibitors
Wenle Xia, Zuguo Liu, Rongrong Zong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
An adenoviral vaccine encoding full-length inactivated human Her2 exhibits potent immunogenicty and enhanced therapeutic efficacy without oncogenicity
Zachary C Hartman, Junping Wei, Takuya Osada, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 13, 2019
Vaccine-Induced Memory CD8<sup>+</sup> T Cells Provide Clinical Benefit in HER2 Expressing Breast Cancer: A Mouse to Human Translational Study
Erika J Crosby, William Gwin, Kimberly Blackwell, et al.
Plos One
|
October 11, 2012
Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system
Nicholas C D'Amato, Julie H Ostrander, Michelle L Bowie, et al.
Cancer Immunology, Immunotherapy : CII
|
April 30, 2013
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
Michael A Morse, Arvind Chaudhry, Elizabeth S Gabitzsch, et al.
Plos One
|
September 2, 2016
X-Ray Psoralen Activated Cancer Therapy (X-PACT)
Mark Oldham, Paul Yoon, Zak Fathi, et al.
Molecular Cancer Therapeutics
|
October 22, 2021
HSP90-Specific nIR Probe Identifies Aggressive Prostate Cancers: Translation from Preclinical Models to a Human Phase I Study
Takuya Osada, Erika J Crosby, Kensuke Kaneko, et al.
Page
of 14